04/09/2019
https://congress.gov...
"This hearing is a critical opportunity for us to check in with the states, those that are on the front lines battling the nation's opioid epidemic."
"Congress needs to continue supporting the states, and this Committee needs to continue conducting oversight of these critical issues."
"The good news is that each state testifying before us today has seen a decrease in their overdose death rates."
"The adequacy of FDA's oversight of the U.S. drug supply has been a longstanding issue for this committee."